Lonasen



Indications and Reactions:

Role Indications Reactions
Secondary
Schizophrenia 40.7%
Product Used For Unknown Indication 11.3%
Drug Use For Unknown Indication 8.1%
Schizophrenia, Undifferentiated Type 5.7%
Insomnia 4.9%
Prophylaxis 3.6%
Akathisia 3.4%
Anxiety 2.4%
Constipation 2.4%
Hallucination, Auditory 2.4%
Hallucination 2.0%
Depression 1.8%
Drug Exposure During Pregnancy 1.6%
Gastric Ulcer 1.6%
Neurogenic Bladder 1.6%
Parkinsonism 1.4%
Schizophrenia, Paranoid Type 1.4%
Delusion 1.2%
Upper Respiratory Tract Infection 1.2%
Diabetes Mellitus 1.0%
Urinary Retention 21.9%
Rhabdomyolysis 15.1%
Cardiac Failure 6.8%
Myocardial Infarction 5.5%
Polydipsia 5.5%
Alanine Aminotransferase Increased 4.1%
Hepatic Function Abnormal 4.1%
Sepsis 4.1%
Acute Myocardial Infarction 2.7%
Alcohol Use 2.7%
Coma 2.7%
Granulocyte Count Decreased 2.7%
Hyperprolactinaemia 2.7%
Malaise 2.7%
Multiple Drug Overdose Intentional 2.7%
Schizophrenia 2.7%
Somnolence 2.7%
Ventricular Extrasystoles 2.7%
Ventricular Septal Defect 2.7%
Vomiting 2.7%
Concomitant
Schizophrenia 44.2%
Product Used For Unknown Indication 10.5%
Schizophrenia, Paranoid Type 7.1%
Bipolar Disorder 4.2%
Constipation 3.9%
Hypertension 3.9%
Substance-induced Psychotic Disorder 3.4%
Sleep Disorder 3.2%
Insomnia 2.9%
Depression 2.4%
Breast Cancer 2.1%
Dermatitis 2.1%
Asthma 1.6%
Epilepsy 1.6%
Lupus Nephritis 1.6%
Benign Prostatic Hyperplasia 1.1%
Gastric Ulcer 1.1%
Hallucination 1.1%
Hyperlipidaemia 1.1%
Iron Deficiency Anaemia 1.1%
Shock Haemorrhagic 8.6%
Sudden Death 8.6%
Hypoxic-ischaemic Encephalopathy 6.9%
Paranoia 6.9%
Rhabdomyolysis 6.9%
Schizophrenia 6.9%
Blood Prolactin Increased 5.2%
Inappropriate Schedule Of Drug Administration 5.2%
Vomiting 5.2%
White Blood Cell Count Increased 5.2%
Dysphagia 3.4%
Eyelid Ptosis 3.4%
Hyperglycaemia 3.4%
Hyperlipidaemia 3.4%
Ileus Paralytic 3.4%
Pneumonia 3.4%
Proctitis 3.4%
Pyrexia 3.4%
Restlessness 3.4%
Salivary Hypersecretion 3.4%